|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||
| Current assets: | |||||||||||||
| Cash and cash equivalents | |||||||||||||
| Accounts receivable | |||||||||||||
| Prepaid expenses | |||||||||||||
| Marketable securities | |||||||||||||
| Investments | |||||||||||||
| Digital assets pledged as collateral | |||||||||||||
| Deferred offering costs | |||||||||||||
| Other current assets | |||||||||||||
| Total current assets | |||||||||||||
| Accounts receivable, non-current | |||||||||||||
| Property and equipment, net | |||||||||||||
| Digital assets, at fair value | |||||||||||||
| Digital assets, at carrying value | |||||||||||||
| Goodwill | |||||||||||||
| Marketable securities | |||||||||||||
| Intangible assets, net | |||||||||||||
| Other assets | |||||||||||||
| Operating lease right-of-use asset, net | |||||||||||||
| Deferred offering costs | |||||||||||||
| Total assets | |||||||||||||
| LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY | |||||||||||||
| Current liabilities: | |||||||||||||
| Accounts payable and accrued expenses | |||||||||||||
| Right of use liability, current portion | |||||||||||||
| Digital asset financing arrangements | |||||||||||||
| Loans payable | |||||||||||||
| Current portion of operating lease liability | |||||||||||||
| Deferred revenue | |||||||||||||
| Other current liabilities | |||||||||||||
| Total current liabilities | |||||||||||||
| Long-term debt, net | |||||||||||||
| Contingent consideration | |||||||||||||
| Future equity obligations | |||||||||||||
| Right of use of liability | |||||||||||||
| Deferred revenue, non-current | |||||||||||||
| Deferred income taxes | |||||||||||||
| Total liabilities | |||||||||||||
| Stockholders' (deficit) equity: | |||||||||||||
| Preferred stock, value | |||||||||||||
| Undesignated Preferred Stock | |||||||||||||
| Series A Preferred Stock | |||||||||||||
| Series B Preferred Stock | |||||||||||||
| Total preferred stock, value | |||||||||||||
| Common stock, $0.00001 par value, 100,000,000 shares authorized, 27,718,159 and 9,909,473 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively | |||||||||||||
| Additional paid-in capital | |||||||||||||
| Treasury stock | |||||||||||||
| Accumulated other comprehensive (loss) income | |||||||||||||
| Accumulated (deficit) | |||||||||||||
| Total stockholders’ (deficit) equity | |||||||||||||
| Total liabilities and stockholders’ (deficit) equity |
Loading...
